Trial intelligence / Profile preview

Continuous vs Single Shot Sciatic Nerve Block for Foot Surgery

NCT01615939Phase 4Terminated

Sponsor
Northwestern University
Start
Jun 2012
Primary completion
Jan 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of ropivacaine in Foot fracture, sponsored by Northwestern University. Started Jun 2012; status: terminated.

02

Drugs

ropivacaine
03

Conditions

Foot fracture

Beyond the preview

Go deeper on NCT01615939.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01615939.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call